- Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trialHenriette Golcher
Department of Surgery, University Hospital Erlangen, Krankenhausstr 12, 91054, Erlangen, Germany
Strahlenther Onkol 191:7-16. 2015..Radiological staging defining resectability was basic information prior to randomization in contrast to adjuvant therapy trials resting on pathological staging...
- To whom do the results of the multicenter, randomized, controlled INSECT trial (ISRCTN 24023541) apply? - assessment of external validityLars Fischer
Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany
BMC Surg 12:2. 2012..ABSTRACT: A response to Seiler et al: Interrupted or continuous slowly absorbable sutures for closure of primary elective midline abdominal incisions: a multicenter randomized trial (..
- Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategyH Golcher
Department of Surgery, University of Erlangen, Krankenhausstr 12, 91054 Erlangen, Germany
Eur J Surg Oncol 34:756-64. 2008..In conclusion a new treatment strategy was developed using multimodality treatment for pancreatic carcinoma deemed to be resectable by CT-scan...